目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. Are there any other notable players in the market?
7.5. What was the impact of Russia-Ukraine war on leading players?

8 Company Profiles
8.1. Sanofi SA
8.2. Bayer AG
8.3. Les Laboratoires Servier
8.4. Novartis AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Russia pharmaceuticals market value: $ billion, 2016-21
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: Russia pharmaceuticals market share: % share, by value, 2021
Table 5: Sanofi SA: key facts
Table 6: Sanofi SA: Annual Financial Ratios
Table 7: Sanofi SA: Key Employees
Table 8: Sanofi SA: Key Employees Continued
Table 9: Bayer AG: key facts
Table 10: Bayer AG: Annual Financial Ratios
Table 11: Bayer AG: Key Employees
Table 12: Bayer AG: Key Employees Continued
Table 13: Les Laboratoires Servier: key facts
Table 14: Les Laboratoires Servier: Key Employees
Table 15: Novartis AG: key facts
Table 16: Novartis AG: Annual Financial Ratios
Table 17: Novartis AG: Key Employees
Table 18: Novartis AG: Key Employees Continued
Table 19: Russia size of population (million), 2017-21
Table 20: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 21: Russia gdp (current prices, $ billion), 2017-21
Table 22: Russia inflation, 2017-21
Table 23: Russia consumer price index (absolute), 2017-21
Table 24: Russia exchange rate, 2017-21

List of Figures
Figure 1: Russia pharmaceuticals market value: $ billion, 2016-21
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Russia pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in Russia, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Russia, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Russia, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2021
Figure 10: Russia pharmaceuticals market share: % share, by value, 2021